RRML - Anti-tissue transglutaminase antibodies in patients with anti glutamate dehydrogenase positive type 1 diabetes mellitus
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2019): 0.945

Rejection rate (2016): 55%

Română English


Clarivate analytics (ISI) Impact factor


Advanced search


Top 10 downloaded articles
- July 2020 -
 
Multiplex ligation-dependent p... 3
Undetectable hemoglobin in a p... 2
Implications of visfatin genet... 2
Antimicrobial activity of diff... 2
The predictive role of platele... 2
Genetic variability of ANG2 -3... 2
Validation of GOD / PAP method... 1
A model for calculating measur... 1
Bioanalytical method validatio... 1
Genetic Polymorphism of DNA re... 1

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 20(3)/2012
XML
TXT

Anti-tissue transglutaminase antibodies in patients with anti glutamate dehydrogenase positive type 1 diabetes mellitus

Gabriela Gurau, Michaela Dobre, Aurel Nechita


Abstract:

The purpose of our study is to determine the prevalence of celiac disease related antibodies (anti-tissue transglutaminase, anti-tTG IgA) in patients with type 1 diabetes mellitus (T1DM) and to compare these results with the general population. We also evaluated the prevalence of anti-tTG IgA in the absence and presence of anti-glutamate dehydrogenase antibodies (anti-GAD) in diabetic subjects. The autoantibodies were evaluated with respect to the clinical status and diabetes control of the patients. The study included 111 children and young adults, 62 boys and 49 girls, with a mean age of 13.42 ± 6.00 years and a duration of diabetes which ranged from 0 to15 years, and 161 control subjects, age and sex matched. Patients who were positive were offered a gastroduodenoscopic examination. Anti-GAD autoantibodies were positive in 68.5% (76/111) patients with T1DM. In T1DM patients with anti-GAD positivity, we found a prevalence of positive anti-tTG IgA 3.94% (3/76) and on T1DM patients without anti-GAD, the anti-tTG IgA positivity was 2.85% (1/35) (nonsignificant differences). Anti-tTG IgA antibodies positivity was higher in patients with T1DM (4/111; 3.6%), compared to controls (1/161; 0.6%). Serological markers are useful in identifying celiac disease patients with T1DM. Celiac disease (CD) related antibodies weren’t more frequent in T1DM patients positive for anti-GAD and no age correlation was observed.

Keywords: celiac disease,diabetes mellitus,anti-tTGIgA,anti-GA

 
  PDF Download full text PDF
(106 KB)
     
 
How to cite
Gurau G, Dobre M, Nechita A. Anti-tissue transglutaminase antibodies in patients with anti glutamate dehydrogenase positive type 1 diabetes mellitus. Rev Romana Med Lab. 2012;20(3):225-32